Pfizer underscores UK commitments in memo (Update)

by Danica Kirka
In this Friday, May 2, 2014 file photo, an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of the Anglo-British firm AstraZeneca, insisting that its promises will be legally binding. In a memo Monday, May 12, 2104 to two parliamentary committees studying its proposed takeover, the U.S. drugmaker laid outs its vision ahead of testimony before the science and business committees. Crucially, the company sought to ease worries that British jobs will be lost and that the nation's science base will be undermined by the potential merger. (AP Photo/Matt Dunham, File)

Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of Anglo-Swedish pharmaceuticals firm AstraZeneca, insisting that its promises will be legally binding.

In a memo Monday to two U.K. parliamentary committees studying its proposed overture, the U.S. drugmaker laid out its vision ahead of its testimony before the science and business committees. Crucially, it sought to ease worries that British jobs will be lost and that the nation's science base eroded by the potential merger.

It repeated promises to complete AstraZeneca's research and development hub in Cambridge and to establish the new company's tax residence in England.

"Delivering on these commitments will make us a stronger company that delivers benefits to patients, value to shareholders, and creates and protects high value jobs," the memo said.

The maker of Viagra has already written to U.K. Prime Minister David Cameron to offer commitments, but the memo bolstered the message, saying the promises were "binding as a matter of English law."

The cash and stock deal has become politically fraught, with much of the debate centering on whether Pfizer can be trusted to honor promises in what would be the biggest foreign takeover of a British business. Cameron has been accused by the opposition Labour Party of being a cheerleader for the deal.

The British leader was forced Sunday in a BBC interview to reject the notion that he was favoring Pfizer. But he also said Britain should not "put up the drawbridge" to outside investment.

Pfizer has made three approaches to AstraZeneca since January—all of which have been rejected. AstraZeneca said Pfizer's latest offer undervalues the company and that a takeover would disrupt its work on a potentially lucrative pipeline of new drugs.

The potential deal comes amid a spate of mergers among pharmaceutical companies, who are seeking to find new ways to grow as generic drugmakers move in to make cheaper versions of products with expiring patents.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

AstraZeneca fends off Pfizer with new growth plan

May 06, 2014

AstraZeneca on Tuesday outlined plans to make sales jump over the next decade, an effort to persuade shareholders the drug maker can do well as an independent company, rather than get bought out by rival ...

Pfizer, Teva reach deal to allow generic Viagra

Dec 17, 2013

Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

Recommended for you

Surrogate offers clues into man with 16 babies

3 hours ago

When the young Thai woman saw an online ad seeking surrogate mothers, it seemed like a life-altering deal: $10,000 to help a foreign couple that wanted a child but couldn't conceive.

Nurses go on strike in Ebola-hit Liberia

3 hours ago

Nurses at Liberia's largest hospital went on strike on Monday, demanding better pay and equipment to protect them against a deadly Ebola epidemic which has killed hundreds in the west African nation.

ALS Ice Bucket Challenge arrives in North Korea

Aug 31, 2014

It's pretty hard to find a novel way to do the ALS Ice Bucket Challenge by now, but two-time Grammy-winning rapper Pras Michel, a founding member of the Fugees, has done it—getting his dousing in the center ...

Cold cash just keeps washing in from ALS challenge

Aug 28, 2014

In the couple of hours it took an official from the ALS Association to return a reporter's call for comment, the group's ubiquitous "ice bucket challenge" had brought in a few million more dollars.

Medtronic spends $350M on another European deal

Aug 27, 2014

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

User comments